Literature DB >> 21576337

Bacillus cereus G9241 makes anthrax toxin and capsule like highly virulent B. anthracis Ames but behaves like attenuated toxigenic nonencapsulated B. anthracis Sterne in rabbits and mice.

Melissa K Wilson1, James M Vergis, Farhang Alem, John R Palmer, Andrea M Keane-Myers, Trupti N Brahmbhatt, Christy L Ventura, Alison D O'Brien.   

Abstract

Bacillus cereus G9241 was isolated from a welder with a pulmonary anthrax-like illness. The organism contains two megaplasmids, pBCXO1 and pBC218. These plasmids are analogous to the Bacillus anthracis Ames plasmids pXO1 and pXO2 that encode anthrax toxins and capsule, respectively. Here we evaluated the virulence of B. cereus G9241 as well as the contributions of pBCXO1 and pBC218 to virulence. B. cereus G9241 was avirulent in New Zealand rabbits after subcutaneous inoculation and attenuated 100-fold compared to the published 50% lethal dose (LD(50)) values for B. anthracis Ames after aerosol inoculation. A/J and C57BL/6J mice were comparably susceptible to B. cereus G9241 by both subcutaneous and intranasal routes of infection. However, the LD(50)s for B. cereus G9241 in both mouse strains were markedly higher than those reported for B. anthracis Ames and more like those of the toxigenic but nonencapsulated B. anthracis Sterne. Furthermore, B. cereus G9241 spores could germinate and disseminate after intranasal inoculation into A/J mice, as indicated by the presence of vegetative cells in the spleen and blood of animals 48 h after infection. Lastly, B. cereus G9241 derivatives cured of one or both megaplasmids were highly attenuated in A/J mice. We conclude that the presence of the toxin- and capsule-encoding plasmids pBCXO1 and pBC218 in B. cereus G9241 alone is insufficient to render the strain as virulent as B. anthracis Ames. However, like B. anthracis, full virulence of B. cereus G9241 for mice requires the presence of both plasmids.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21576337      PMCID: PMC3147598          DOI: 10.1128/IAI.00205-11

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  The history of biological warfare. Human experimentation, modern nightmares and lone madmen in the twentieth century.

Authors:  Friedrich Frischknecht
Journal:  EMBO Rep       Date:  2003-06       Impact factor: 8.807

2.  Differences in susceptibility of inbred mice to Bacillus anthracis.

Authors:  S L Welkos; T J Keener; P H Gibbs
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

3.  Clinical spectrum of infection due to Bacillus species.

Authors:  D C Ihde; D Armstrong
Journal:  Am J Med       Date:  1973-12       Impact factor: 4.965

4.  Severe clinical conditions associated with Bacillus cereus and the apparent involvement of exotoxins.

Authors:  P C Turnbull; K Jørgensen; J M Kramer; R J Gilbert; J M Parry
Journal:  J Clin Pathol       Date:  1979-03       Impact factor: 3.411

5.  The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation.

Authors:  G M Zaucha; L M Pitt; J Estep; B E Ivins; A M Friedlander
Journal:  Arch Pathol Lab Med       Date:  1998-11       Impact factor: 5.534

6.  Murine model of pulmonary anthrax: kinetics of dissemination, histopathology, and mouse strain susceptibility.

Authors:  C Rick Lyons; Julie Lovchik; Julie Hutt; Mary F Lipscomb; Eugenia Wang; Sara Heninger; Lucy Berliba; Kristin Garrison
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

7.  Non-gastrointestinal Bacillus cereus infections: an analysis of exotoxin production by strains isolated over a two-year period.

Authors:  P C Turnbull; J M Kramer
Journal:  J Clin Pathol       Date:  1983-10       Impact factor: 3.411

8.  Demonstration of a capsule plasmid in Bacillus anthracis.

Authors:  B D Green; L Battisti; T M Koehler; C B Thorne; B E Ivins
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

9.  Identification of anthrax toxin genes in a Bacillus cereus associated with an illness resembling inhalation anthrax.

Authors:  Alex R Hoffmaster; Jacques Ravel; David A Rasko; Gail D Chapman; Michael D Chute; Chung K Marston; Barun K De; Claudio T Sacchi; Collette Fitzgerald; Leonard W Mayer; Martin C J Maiden; Fergus G Priest; Margaret Barker; Lingxia Jiang; Regina Z Cer; Jennifer Rilstone; Scott N Peterson; Robbin S Weyant; Darrell R Galloway; Timothy D Read; Tanja Popovic; Claire M Fraser
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-21       Impact factor: 11.205

10.  Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States.

Authors:  J A Jernigan; D S Stephens; D A Ashford; C Omenaca; M S Topiel; M Galbraith; M Tapper; T L Fisk; S Zaki; T Popovic; R F Meyer; C P Quinn; S A Harper; S K Fridkin; J J Sejvar; C W Shepard; M McConnell; J Guarner; W J Shieh; J M Malecki; J L Gerberding; J M Hughes; B A Perkins
Journal:  Emerg Infect Dis       Date:  2001 Nov-Dec       Impact factor: 6.883

View more
  18 in total

1.  Host cell cytotoxicity and cytoskeleton disruption by CerADPr, an ADP-ribosyltransferase of Bacillus cereus G9241.

Authors:  Nathan C Simon; James M Vergis; Avesta V Ebrahimi; Christy L Ventura; Alison D O'Brien; Joseph T Barbieri
Journal:  Biochemistry       Date:  2013-03-20       Impact factor: 3.162

2.  Bacillus cereus Certhrax ADP-ribosylates vinculin to disrupt focal adhesion complexes and cell adhesion.

Authors:  Nathan C Simon; Joseph T Barbieri
Journal:  J Biol Chem       Date:  2014-02-26       Impact factor: 5.157

Review 3.  The Bacillus cereus Group: Bacillus Species with Pathogenic Potential.

Authors:  Monika Ehling-Schulz; Didier Lereclus; Theresa M Koehler
Journal:  Microbiol Spectr       Date:  2019-05

4.  Development of a set of three real-time loop-mediated isothermal amplification (LAMP) assays for detection of Bacillus anthracis, the causative agent of anthrax.

Authors:  Swati Banger; Vijai Pal; N K Tripathi; A K Goel
Journal:  Folia Microbiol (Praha)       Date:  2021-04-09       Impact factor: 2.099

5.  What Is Anthrax?

Authors:  William A Bower; Katherine A Hendricks; Antonio R Vieira; Rita M Traxler; Zachary Weiner; Ruth Lynfield; Alex Hoffmaster
Journal:  Pathogens       Date:  2022-06-16

6.  The roles of AtxA orthologs in virulence of anthrax-like Bacillus cereus G9241.

Authors:  Jennifer M Scarff; Malik J Raynor; Yuliya I Seldina; Christy L Ventura; Theresa M Koehler; Alison D O'Brien
Journal:  Mol Microbiol       Date:  2016-09-04       Impact factor: 3.501

7.  Vaccine protection against Bacillus cereus-mediated respiratory anthrax-like disease in mice.

Authors:  So-Young Oh; Hannah Maier; Jay Schroeder; G Stefan Richter; Derek Elli; James M Musser; Lauriane E Quenee; Dominique M Missiakas; Olaf Schneewind
Journal:  Infect Immun       Date:  2013-01-14       Impact factor: 3.441

8.  Bacillus cereus G9241 S-layer assembly contributes to the pathogenesis of anthrax-like disease in mice.

Authors:  Ya-Ting Wang; So-Young Oh; Antoni P A Hendrickx; J M Lunderberg; Olaf Schneewind
Journal:  J Bacteriol       Date:  2012-11-30       Impact factor: 3.490

9.  Certhrax Is an Antivirulence Factor for the Anthrax-Like Organism Bacillus cereus Strain G9241.

Authors:  Yuliya I Seldina; Courtney D Petro; Stephanie L Servetas; James M Vergis; Christy L Ventura; D Scott Merrell; Alison D O'Brien
Journal:  Infect Immun       Date:  2018-05-22       Impact factor: 3.441

10.  Immunization of mice with formalin-inactivated spores from avirulent Bacillus cereus strains provides significant protection from challenge with Bacillus anthracis Ames.

Authors:  James M Vergis; Christopher K Cote; Joel Bozue; Farhang Alem; Christy L Ventura; Susan L Welkos; Alison D O'Brien
Journal:  Clin Vaccine Immunol       Date:  2012-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.